Mitsubishi Chemical

Mitsubishi Chemical and Accenture have established the joint venture Rix Business Partners, which launched on May 1 through the subsidiary DIA-RIX and is based in Marunouchi, Tokyo. Mitsubishi Chemical holds 81% of the shares and Accenture 19%. The company, led by Shinichi Nakata, employs 255 people. Its goal is to develop an AI-supported platform to support and standardize corporate functions—such as administration, administrative services and facility management—at domestic locations to improve transparency and cross-site management. » More on de.investing.com

Mitsubishi Chemical reported EPS of -68.07 yen versus an expected 10.65 yen, thus missing the forecast by a wide margin. Quarterly revenue was 966.71 billion yen, slightly above expectations of 946.39 billion yen. The stock rose 8.48% to 1,007 yen. For fiscal 2025, revenue fell 9.3% to 3,704 billion yen and profit attributable to owners dropped to 11.8 billion yen; for 2026 the company forecasts revenue rising to 3,800 billion yen and net profit of 227 billion yen, driven by Specialty Materials and Industrial Gases. » More on de.investing.com

Mitsubishi Chemical reported a Q3 FY2025 revenue decline of 8% to ¥2,737.3 billion, while net profit attributable to owners rose 77% to ¥105.4 billion, mainly due to the sale of Mitsubishi Tanabe Pharma. Core operating income fell slightly by 2% to ¥185.6 billion; operating income declined more sharply. Segments moved unevenly: Industrial Gases remained strong, Specialty Materials improved, and MMA & Derivatives collapsed. The company maintained its full-year target for core operating income, cut its net profit forecast and missed earnings per share; the stock fell by about 3.2% after the release. » More on de.investing.com